Published in J Chronic Dis on January 01, 1977
Evaluating the public health impact of health promotion interventions: the RE-AIM framework. Am J Public Health (1999) 23.22
Changes in restricted human cellular DNA fragments containing globin gene sequences in thalassemias and related disorders. Proc Natl Acad Sci U S A (1978) 6.46
Side effects of hypotensive agents evaluated by a self-administered questionnaire. Br Med J (1973) 5.65
The effects of antihypertensive therapy on the quality of life. N Engl J Med (1986) 5.32
Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli. Am J Psychiatry (2000) 4.87
Register of newly diagnosed diabetic children. Br Med J (1975) 3.53
A symptom questionnaire for hypertensive patients. J Chronic Dis (1974) 3.51
Effects of calcium-channel blockade in older patients with diabetes and systolic hypertension. Systolic Hypertension in Europe Trial Investigators. N Engl J Med (1999) 3.43
Disposable syringes for insulin injection. Br Med J (1979) 3.31
The impact of treatment with levodopa on Parkinson's disease. Q J Med (1980) 3.14
The control of experimental Escherichia coli diarrhoea in calves by means of bacteriophages. J Gen Microbiol (1987) 2.76
Computer-based hypertension clinic records: a co-operative study. Br Med J (1974) 2.24
Confidence intervals. Lancet (1987) 2.21
Islet-cell antibodies in diabetes mellitus. Lancet (1976) 2.20
Impairment of renal function with increasing blood lead concentrations in the general population. The Cadmibel Study Group. N Engl J Med (1992) 2.17
Randomised controlled trial of computer-held medical records in hypertensive patients. Br Med J (1976) 2.15
Change in symptoms of hypertensive patients after referral to hospital clinic. Br Heart J (1976) 2.13
Prevalence of visual impairment in people aged 75 years and older in Britain: results from the MRC trial of assessment and management of older people in the community. Br J Ophthalmol (2002) 2.03
Response to antihypertensive therapy in older patients with sustained and nonsustained systolic hypertension. Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Circulation (2000) 1.98
Syst-Eur. A multicentre trial on the treatment of isolated systolic hypertension in the elderly: objectives, protocol, and organization. Aging (Milano) (1991) 1.93
Steroid aerosols in asthma: an assessment of betamethasone valerate and a 12-month study of patients on maintenance treatment. Br Med J (1974) 1.85
Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J Biol Chem (1998) 1.84
Syringes for diabetics. Br Med J (Clin Res Ed) (1985) 1.82
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey. Br J Ophthalmol (1975) 1.79
Area deprivation, social class, and quality of life among people aged 75 years and over in Britain. Int J Epidemiol (2005) 1.79
Association between intraocular pressure and loss of visual field in chronic simple glaucoma. Br J Ophthalmol (1990) 1.76
How far should blood pressure be lowered? N Engl J Med (1992) 1.76
The drug treatment of hypertension. Practitioner (1971) 1.75
The retinal blood flow in diabetes. Diabetologia (1975) 1.72
Experimental retinal branch vein occlusion. Am J Ophthalmol (1970) 1.72
Fibrinogen: a possible link between social class and coronary heart disease. Br Med J (Clin Res Ed) (1985) 1.67
The MRC trial of assessment and management of older people in the community: objectives, design and interventions [ISRCTN23494848]. BMC Health Serv Res (2002) 1.67
Deprenyl in Parkinson's disease. Lancet (1977) 1.66
How obstetricians manage hypertension in pregnancy. Br Med J (1978) 1.56
Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. Hypertension (1992) 1.53
The prognosis of falls in elderly people living at home. Age Ageing (1999) 1.52
Relation of the complications of diabetes to the clinical state. Proc R Soc Med (1967) 1.50
Long-term antihypertensive drug treatment and blood pressure control in three hospital hypertension clinics. Br Heart J (1980) 1.49
Is aspirin safe for patients with heart failure? Br Heart J (1995) 1.49
Factors influencing the survival and multiplication of bacteriophages in calves and in their environment. J Gen Microbiol (1987) 1.49
GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest (2004) 1.49
Prognosis in adult asthma: a national study. Br Med J (Clin Res Ed) (1987) 1.49
Cutaneous capillary resistance and retinal haemorrhage in diabetes. Diabetologia (1971) 1.47
Vitamin C and blood pressure. J Hypertens (1990) 1.46
Blood pressure measurement in patients with rate controlled atrial fibrillation using mercury sphygmomanometer and Omron HEM-750CP deice in the clinic setting. J Hum Hypertens (2006) 1.45
Trial of combination of guanethidine and oxprenolol in hypertension. Br Med J (1976) 1.44
Calcium channel blockers, ACE inhibitors, and the risk of cancer in hypertensive patients: a report from the Department of Health Hypertension Care Computing Project (DHCCP) J Hum Hypertens (2000) 1.44
Bilateral spontaneous pneumothorax as the presenting feature in lymphangioleiomyomatosis. Respir Med (1995) 1.43
The effect of oral folic acid upon plasma homocysteine, endothelial function and oxidative stress in patients with type 1 diabetes and microalbuminuria. Int J Clin Pract (2008) 1.42
Diabetic erectile dysfunction--an indicator of generalised endothelial function per se? Int J Clin Pract (2006) 1.41
Identification of residues in the monocyte chemotactic protein-1 that contact the MCP-1 receptor, CCR2. Biochemistry (1999) 1.40
Salt intake and blood pressure in the general population: a controlled intervention trial in two towns. J Hypertens (1988) 1.39
Analgesia and satisfaction in childbirth (the Queen Charlotte's 1000 Mother Survey). Lancet (1982) 1.39
Controlling hypertension in the elderly. QJM (2000) 1.37
Selective recording in blood pressure readings may increase subsequent mortality. QJM (2002) 1.33
Environmental factors affecting paracetamol metabolism in London factory and office workers. Br J Clin Pharmacol (1980) 1.32
Oral therapy in diabetes. J R Coll Physicians Lond (1972) 1.32
Anaphylactoid reaction to N-acetylcysteine. Lancet (1979) 1.31
"Off period" dystonia and "on period" choreoathetosis in levodopa-treated patients with Parkinson's disease. Lancet (1977) 1.30
The place of phenformin in the treatment of diabetes. Postgrad Med J (1969) 1.30
Objective markers of condom failure. Sex Transm Dis (1998) 1.30
Deprenyl administration in man: a selective monoamine oxidase B inhibitor without the 'cheese effect'. Psychopharmacology (Berl) (1978) 1.29
The consumers' attitude to obstetric care. Br J Obstet Gynaecol (1984) 1.27
Streptokinase in central retinal vein occlusion: a controlled clinical trial. Br Med J (1976) 1.26
Medical treatment of spasmodic torticollis. Lancet (1972) 1.23
The effect of withdrawing antihypertensive therapy: a review. J Hypertens (1988) 1.23
Joint pain and quality of life; results of a randomised trial. Br J Clin Pharmacol (1989) 1.22
Urinary cadmium and lead concentrations and their relation to blood pressure in a population with low exposure. Br J Ind Med (1984) 1.20
Intraocular pressure and systemic blood pressure in the elderly. Br J Ophthalmol (1975) 1.20
Initial care of hypertensive patients. Influence of different types of clinical records. Br Heart J (1977) 1.18
Hydralazine, antinuclear antibodies, and the lupus syndrome. Br Med J (Clin Res Ed) (1982) 1.17
Risk factors for death in treated hypertensive patients. Report from the D.H.S.S. Hypertension Care Computing Project. Lancet (1979) 1.17
Community care compared with hospital outpatient care for hypertensive patients. Br Med J (Clin Res Ed) (1982) 1.17
Isolation and chemical composition of the cytoplasmic membrane of the archaebacterium Methanospirillum hungatei. J Biol Chem (1983) 1.16
Platelet adhesiveness and aggregation in relation to diabetic retinopathy. Diabetologia (1971) 1.15
Factors influencing the incidence of neonatal jaundice. Br Med J (1978) 1.15
Reversed anaphylactic reaction of leucocytes in intrinsic asthma. Clin Allergy (1971) 1.14
Environmental factors affecting antipyrine metabolism in London factory and office workers. Br J Clin Pharmacol (1979) 1.14
Ammonia/potassium exchange in methanogenic bacteria. J Biol Chem (1984) 1.14
Identification of surface residues of the monocyte chemotactic protein 1 that affect signaling through the receptor CCR2. Biochemistry (1999) 1.14
Sustained levodopa therapy in parkinsonism. Lancet (1973) 1.14
Visit frequency for essential hypertension: observed associations. J Fam Pract (1989) 1.13
The influence of menopause on blood pressure. J Hum Hypertens (1989) 1.13
Effect of changes in intraocular pressure on the retinal microcirculation. Br J Ophthalmol (1974) 1.13
Influence of liver disease and environmental factors on hepatic monooxygenase activity in vitro. Eur J Clin Pharmacol (1981) 1.12
The relationship between both sodium and potassium intake and blood pressure in London Civil Servants. A report from the Whitehall Department of Environment Study. J Chronic Dis (1986) 1.12
Embryogenesis of the gingival cyst. J Clin Periodontol (1983) 1.12
Streptokinase in the treatment of central retinal vein occlusion. A controlled trial. Trans Ophthalmol Soc U K (1974) 1.11
Phenformin as Adjuvant Oral Therapy in Diabetes. Br Med J (1961) 1.10
Stroke death and unemployment in London. J Epidemiol Community Health (1991) 1.10
Diabetes mellitus, Addison's disease and pernicious anaemia. Postgrad Med J (1968) 1.10
Cotton-wool spots in diabetic retinopathy. Diabetes (1969) 1.09
Letter: Bromocriptine in parkinsonism. Lancet (1975) 1.08
Eye symptoms in patients taking propranolol and other hypotensive agents. Br J Clin Pharmacol (1977) 1.08
Endocrine aspects of bromocriptine therapy in Parkinsonism. J Neural Transm (1978) 1.08
Factors affecting antipyrine metabolism in West African villagers. Clin Pharmacol Ther (1976) 1.08
British Diabetic Association: new criteria and classification for diabetes mellitus. Br Med J (Clin Res Ed) (1983) 1.07
Assessment of the need for continued oral therapy in diabetics. Br Med J (1972) 1.07